Skip to main content
Theodore Johnson, MD, Pediatric Hematology & Oncology, Augusta, GA

TheodoreSamuelJohnsonMD

Pediatric Hematology & Oncology Augusta, GA

Assistant Professor, Pediatrics, Medical College of Georgia at Georgia Health Sciences University

Are you Dr. Johnson?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 44 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    1120 15th St
    # CN-4141A
    Augusta, GA 30912
    Phone+1 706-721-3626
    Fax+1 706-721-4804

Summary

  • Dr. Theodore Johnson, MD is a pediatric hematologist/oncologist in Augusta, Georgia. He is currently licensed to practice medicine in Georgia, Ohio, and South Carolina. He is affiliated with WellStar MCG Health, affiliated with Medical College of Georgia and is an Assistant Professor at Medical College of Georgia at Georgia Health Sciences University.

Education & Training

  • Cincinnati Children's Hospital Medical Center
    Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2007 - 2010
  • Medical College of Georgia
    Medical College of GeorgiaResidency, Pediatrics, 2004 - 2007
  • Medical College of Georgia at Augusta University
    Medical College of Georgia at Augusta UniversityClass of 2004

Certifications & Licensure

  • GA State Medical License
    GA State Medical License 2010 - 2026
  • SC State Medical License
    SC State Medical License 2006 - 2017
  • OH State Medical License
    OH State Medical License 2007 - 2012
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Novel Immunotherapy Beneficial to Children with Relapsed Brain Tumours: Research
    Novel Immunotherapy Beneficial to Children with Relapsed Brain Tumours: ResearchApril 25th, 2023
  • Novel Treatment Regimen Appears Well Tolerated, Beneficial to Children with Relapsed Brain Tumors
    Novel Treatment Regimen Appears Well Tolerated, Beneficial to Children with Relapsed Brain TumorsApril 25th, 2023